Credit-linked notes / synthetic securitizations

Synthetic securitization transfers credit risk without selling assets. The sponsor keeps the loans on its balance sheet and buys protection via a credit derivative; investors take the other side of that derivative through a note structure. This topic covers when synthetics make sense, how the mechanics work, and how to evaluate an investment or sponsorship decision.

When synthetic structures make sense

Synthetic securitization exists because sometimes you want to transfer risk without transferring ownership. Your decision comes down to whether you need funding or capital relief.

Use synthetic when

Regulatory capital relief is the primary goal. Banks running up against CET1 constraints can shed risk-weighted assets without selling loans. This is the dominant use case, accounting for EUR 80B+ in European issuance annually.

Legal ownership must stay with you. Customer relationships, servicing rights, or competitive dynamics may require you to remain the lender of record. Synthetic structures transfer economics while preserving the legal relationship.

True sale would trigger adverse consequences. Some jurisdictions impose withholding taxes on asset transfers, or accounting rules would require unfavorable gain/loss recognition. Synthetic structures avoid true sale mechanics entirely.

The reference portfolio is hard to transfer. Committed but undrawn facilities, project finance loans, and revolving credit lines are difficult to assign. Synthetics reference these exposures without assignment.

Speed matters. A synthetic can close in 8-12 weeks; cash securitization often takes 4-6 months. If you need capital relief by quarter-end, synthetic is faster.

Do NOT use synthetic when

You need funding. Synthetic securitization does not generate cash proceeds for the sponsor. If you need liquidity, you need cash securitization or a credit facility.

Full balance sheet derecognition is required. Synthetic assets remain on your balance sheet under IFRS and US GAAP. If accounting derecognition drives your decision, synthetic will not work.

Your regulator is skeptical. Some jurisdictions lack clear frameworks for Significant Risk Transfer. If regulatory recognition is uncertain, the capital relief value may not materialize.

Investors want cash flow certainty. Traditional securitization investors who underwrite to amortization schedules and waterfall mechanics may not engage with derivative-based structures.

Synthetic vs. cash securitization

Feature	Cash Securitization	Synthetic Securitization
Asset ownership	Sold to SPV	Stays with sponsor
Funding generated	Yes (note proceeds)	No
Accounting treatment	Potential derecognition	Assets remain on balance sheet
True sale complexity	Significant	None
Operational burden	Asset servicing transfers possible	Sponsor continues servicing
Time to close	4-6 months	8-12 weeks
Investor base	Traditional ABS buyers	Credit funds, insurers

Primary market segments

Bank SRT transactions represent the largest segment. European banks have led adoption, with EUR 80-100B annual issuance. US banks are increasingly active following 2024 regulatory clarity.

Trade finance synthetics leverage the short duration and granularity of trade portfolios. Typical programs are revolving, with 12-month reference portfolios refreshing quarterly.

Corporate CLNs allow non-bank companies to hedge concentrated credit exposures (key customers, suppliers) without the counterparty knowing.

Insurance-linked structures transfer credit risk embedded in insurance portfolios, often through rated note feeders designed for Solvency II optimization.

Structure mechanics and documentation

Core structural components

Reference portfolio. The defined set of loans or exposures whose credit risk you are transferring. This can be:

Static: Fixed at closing, no substitutions allowed
Managed/revolving: Substitutions permitted within eligibility criteria

Your reference portfolio documentation specifies:

Eligibility criteria (asset type, credit quality, geography)
Concentration limits (single obligor, sector, country)
Exclusion events (what removes an exposure from the pool)

Credit derivative. The contract between sponsor and SPV that transfers risk. Two main types:

Credit default swap (CDS): Sponsor (protection buyer) pays periodic premium; SPV (protection seller) pays on credit events. This is the standard structure.

Total return swap (TRS): Transfers full economic exposure including market value changes. More complex, used when mark-to-market risk transfer is needed.

SPV structure. A bankruptcy-remote entity that:

Issues notes to investors
Holds collateral (note proceeds invested in eligible securities)
Enters into credit derivative with sponsor
Passes premium income to noteholders as coupon
Releases collateral to cover losses upon credit events

Collateral arrangement. For funded CLNs, note proceeds are invested in high-quality collateral:

Money market instruments (typical yield: SOFR + 5-20bps)
Government bonds (US Treasuries, Bunds)
Repo arrangements

Collateral quality directly affects investor return and structure risk. Higher-yielding collateral adds basis risk.

Credit event definitions

Getting credit event definitions right is critical. Misalignment between how you recognize losses internally and how the CLN defines credit events creates basis risk.

Standard ISDA credit events (2014 definitions):

Event	Definition	Notes
Bankruptcy	Insolvency, liquidation, or similar proceeding	Clearest trigger
Failure to pay	Missed payment beyond grace period (typically 30 days)	Payment threshold usually $1M+
Restructuring	Adverse modification of loan terms	Most contentious; multiple variants exist

Customized definitions for loan portfolios:

Writedown/charge-off: Loss recognized per sponsor’s accounting policy
Expected loss recognition: IFRS 9 Stage 3 classification
Delinquency-based triggers: 90+ days past due (common in consumer portfolios)

Important: Restructuring is the most disputed credit event. “Mod-R,” “Mod-Mod-R,” and “No-R” variants have different scope. Ensure your CLN definition matches your loss recognition practice.

Payment mechanics

Premium leg (what sponsor pays):

Periodic premium (quarterly standard)
Quoted as spread over reference rate (e.g., SOFR + 500bps)
Paid on outstanding notional of protected tranche
Premium paid regardless of whether credit events occur

Protection leg (what SPV pays on credit events):

Loss amount calculated per agreed methodology
Deducted from collateral (reducing amount available to repay notes)
Allocated to tranches in reverse seniority (equity first, then mezzanine, then senior)

Settlement mechanics:

Cash settlement: Loss amount calculated; collateral reduced by that amount
Physical settlement: Sponsor delivers defaulted loans; SPV pays par (rare in CLNs)

Cash flow waterfall:

INTEREST WATERFALL
1. Trustee/admin fees
2. Credit derivative premium (from sponsor)
3. Collateral income
4. Swap costs (if hedging rate/FX)
5. Senior note interest
6. Mezzanine note interest
7. Equity note interest (if any)
8. Residual to reserve/equity

PRINCIPAL WATERFALL (at maturity or upon credit events)
1. Loss allocation (reverse seniority)
2. Senior note principal
3. Mezzanine note principal
4. Equity note principal

Tranche structure and economics

Your return and risk depend entirely on where you sit in the capital structure. The attachment and detachment points of your tranche determine your break-even default rate and expected return.

Capital structure hierarchy

First-loss / equity tranche (typically 0-5% or 0-7%)

Bears first dollar of loss on reference portfolio
Highest yield: 12-25%+ expected return
Usually retained by sponsor (regulatory skin-in-the-game)
Sized to absorb expected losses plus buffer

Mezzanine tranche (typically 5-15% or 7-20%)

Absorbs losses after first-loss is exhausted
Primary investment target for credit funds and insurers
Expected returns: 6-15% depending on attachment, portfolio, and structure
This is where investors earn excess spread for taking tail risk

Senior tranche (typically 15%+ to 100%)

Protected by subordination of junior tranches
Often unfunded (guarantee rather than note)
Lower yield: 1-3% over reference rate
May be retained by sponsor or placed with conservative investors

Pricing mechanics

CLN spreads reflect expected loss, loss volatility, and structural features:

Spread = Expected loss + Risk premium + Structural adjustments

Expected loss depends on:

Portfolio PD (probability of default)
Portfolio LGD (loss given default)
Attachment and detachment points
Default correlation

Market benchmarks:

CDS indices (iTraxx Europe Main, CDX IG) for investment-grade reference
Comparable CLN transactions (limited price transparency)
Single-name CDS on largest obligors in portfolio

Typical spread ranges (as of late 2025):

Tranche	Attachment	Expected Spread
Equity (retained)	0-7%	15-25%+
Junior mezz	7-10%	8-12%
Senior mezz	10-15%	5-8%
Senior	15-100%	1-3%

Illustrative pricing. See pricing disclaimer.

Break-even analysis

Your break-even default rate tells you how much the portfolio must lose before your principal is impaired.

For a mezzanine tranche at 7-15% attachment/detachment:

If cumulative portfolio loss stays below 7%, you receive full principal back
If loss reaches 15%+, your principal is fully wiped out
Break-even: 7% cumulative loss on reference portfolio

Key sensitivity: correlation. Higher default correlation means defaults cluster together. This creates fatter tails, which hurts mezzanine investors:

Low correlation (10-15%): Losses spread evenly; mezzanine is safer
High correlation (30%+): Either few defaults or many; mezzanine faces tail risk

Return scenarios

Base case (70-80% probability): Portfolio performs within expected parameters. You receive premium income throughout the deal, absorb modest losses within expectations, and achieve target return.

Stress case (15-25% probability): Recession or sector dislocation increases defaults to 2-3x expected levels. Mezzanine tranche experiences principal write-down of 20-50%. IRR drops to 0-5%.

Severe stress (5% probability): Systemic crisis with widespread defaults. Mezzanine tranche fully impaired. Equity tranche wiped out early in deal life.

Upside (limited): Unlike equity investments, CLNs have capped upside. If portfolio performs better than expected, you receive your premium but no additional return. Sponsor may exercise call option, ending deal at par.

Documentation framework

CLN documentation is bespoke and complex. Plan for 10-15 key documents and 8-12 weeks of negotiation for a new program.

Key transaction documents

Offering memorandum / prospectus

Reference portfolio description and eligibility criteria
Risk factors disclosure
Terms and conditions of notes
Use for investor due diligence

Credit derivative agreement

ISDA Master Agreement + Schedule + Confirmation
Credit event definitions (the most negotiated section)
Premium payment mechanics
Settlement procedures
Calculation agent appointment

Trust deed / indenture

Note terms and conditions
Payment waterfall
Events of default and remedies
Trustee duties and indemnification
Noteholder meeting procedures

Collateral agreement

Eligible collateral criteria and haircuts
Reinvestment guidelines
Custody and safekeeping arrangements
Margin call and top-up mechanics

Portfolio management agreement (for managed deals)

Substitution criteria and limits
Manager discretion boundaries
Reporting frequency and format
Performance triggers

Key negotiation points

Credit event definitions What you want: Alignment between how you actually recognize losses and how the CLN pays out. Misalignment creates basis risk where you suffer a loss but cannot claim on the CLN.

What to negotiate:

Loss recognition triggers (accounting vs. credit policy)
Restructuring scope (which modifications count)
Loss measurement methodology
Timing of credit event determination

Collateral quality What you want (as investor): High-quality, liquid collateral that will be there when you need it.

What to watch:

Minimum credit rating requirements
Concentration limits
What happens if collateral issuer defaults?
Reinvestment discretion limits

Substitution rights What you want (as investor): Protection against adverse selection (sponsor swapping good credits for bad ones).

Key protections:

Substitute must meet original eligibility criteria
Quality tests (average rating, concentration limits)
Volume limits (e.g., max 20% substitution per year)
Notice and objection rights

Call provisions Standard terms:

Non-call period: 2-3 years typically
Call at par after non-call
Clean-up call when portfolio falls below threshold (e.g., 10% of original)
Regulatory change call (if capital treatment changes adversely)

Regulatory and accounting treatment

The value proposition of synthetic securitization depends entirely on regulatory recognition. If your regulator does not accept your structure as valid Significant Risk Transfer, you do not get capital relief.

Bank capital treatment (Basel framework)

SRT test requirements: To claim RWA reduction, you must demonstrate:

Commensurate risk transfer: Meaningful reduction in credit risk
Retention requirement: Sponsor retains material first-loss (typically 5%+)
Quantitative tests: RWA reduction proportionate to risk transferred
Ongoing compliance: No recourse, call at fair value only

Pre-notification: Most regulators require advance notification (60-90 days) before closing SRT transactions.

Jurisdictional differences

Jurisdiction	Framework Clarity	Pre-Notification	Approval Rate
ECB (Eurozone)	High	Required (60 days)	~85%
PRA (UK)	High	Required (90 days)	~80%
Fed (US)	Improving (2024+)	Case-by-case	Growing
OSFI (Canada)	Moderate	Required	Selective
APRA (Australia)	Limited	Case-by-case	Limited precedent

Illustrative pricing. See pricing disclaimer.

Note: Engage your regulator early. Informal pre-consultation before formal notification significantly improves outcomes.

Capital relief calculation

Example: EUR 2B corporate loan portfolio

Item	Before SRT	After SRT
Portfolio	EUR 2,000M	EUR 2,000M
Average RW	60%	60%
RWA	EUR 1,200M	EUR 1,200M
Transferred tranche (7-15%)	-	EUR 160M
RWA reduction (proportionate)	-	EUR 120-150M
CET1 freed (at 8%)	-	EUR 10-12M

Economics test: Is capital relief worth the premium cost?

Premium: 500bps × EUR 160M = EUR 8M/year
Capital freed: EUR 10-12M
Return on freed capital if redeployed at 10%: EUR 1.0-1.2M/year
Net cost: EUR 6.8-7.0M/year
Justified if: (a) capital constraint is binding, or (b) redeployment return exceeds 60%+

Accounting treatment

Sponsor (IFRS 9 / US GAAP):

Reference assets remain on balance sheet (no derecognition)
Credit derivative recognized at fair value through P&L
Hedge accounting possible if designation criteria met
Premium paid expensed over deal life

Investor (IFRS 9 / US GAAP):

Notes typically at amortized cost or FVTPL
Credit impairment assessment required (IFRS 9 ECL / CECL)
May require embedded derivative analysis

Insurance investor considerations (Solvency II)

CLN investments attract spread risk capital charge under Solvency II:

Look-through to underlying reference portfolio may be possible
Rated notes receive more favorable treatment
Duration affects capital charge (longer = higher)

NAIC treatment (US insurers):

Filing with SVO for designation
Treatment depends on structure and rating
Private placement letter required

Tax considerations

Cross-border withholding:

Premium payments may be subject to withholding tax
Structure to minimize: Treaty benefits, SPV jurisdiction selection
Common SPV jurisdictions: Ireland, Luxembourg, Netherlands

US investor considerations:

FATCA compliance required
ECI (effectively connected income) analysis for unfunded positions
PFIC rules may apply to certain structures

Use cases and worked examples

Worked example 1: European bank SRT transaction

Situation: A European bank holds a EUR 2B corporate loan portfolio with 60% average risk weight. CET1 ratio is at 11.5%, approaching the bank’s internal 11.0% floor. The bank needs capital relief without selling customer relationships.

Structure:

Tranche	Attachment	Size	Investor
First-loss	0-7%	EUR 140M	Bank (retained)
Mezzanine	7-15%	EUR 160M	Credit funds
Senior	15-100%	EUR 1,700M	Bank (unfunded)

Economics:

Premium calculation:
- Mezzanine spread: 500bps
- Annual premium: EUR 160M × 5.00% = EUR 8M

Capital impact:
- Portfolio RWA before: EUR 2B × 60% = EUR 1,200M
- Mezzanine RWA relief: ~EUR 130M
- CET1 freed: EUR 130M × 8% = EUR 10.4M
- New CET1 ratio: 11.5% → 11.9% (approximate)

Return analysis:
- Cost: EUR 8M/year
- Capital freed: EUR 10.4M
- Break-even redeployment return: 77%
- If capital constraint is binding: Transaction is positive NPV
  (capital freed allows new lending at 15% ROE)

Investor perspective (mezzanine buyer):

Investment: EUR 20M in 7-15% mezzanine tranche
Coupon: EURIBOR + 500bps (currently ~8.5% all-in)
Expected loss: 0.3-0.5% annually (based on portfolio analysis)
Expected return: 7.5-8.0% net of expected losses

Break-even analysis:
- Tranche attachment: 7%
- Tranche detachment: 15%
- Portfolio must lose 7%+ before principal impairment
- Historical corporate default rate: 1-2% annually
- Cushion: 3-4 years of defaults before attachment breached

Worked example 2: trade finance revolving CLN

Situation: A global bank has a $5B trade finance portfolio with 0.3% expected annual loss but 100% risk weight (SME obligors). The bank wants ongoing capital optimization.

Structure:

Feature	Specification
Reference portfolio	$500M revolving (12-month assets)
First-loss (retained)	0-3% ($15M)
Mezzanine (placed)	3-8% ($25M)
Senior (unfunded)	8-100%
Portfolio refresh	Quarterly
Program tenor	5 years

Why revolving works:

Trade finance assets mature in 90-180 days
Portfolio constantly refreshes within eligibility criteria
Investors accept revolving exposure due to granularity and track record
Bank gets ongoing capital relief vs. point-in-time transaction

Investor return calculation:

Mezzanine coupon: SOFR + 400bps (~9% all-in)
Expected loss at 3-8%: Near zero (portfolio expected loss 0.3%)
Modeled stress loss: 2.0% cumulative over 5 years
Attachment cushion: 3% (covers 10x expected losses)

Expected return: 8.5-9.0% with high confidence
Risk: Macro event driving concentrated trade finance defaults

Worked example 3: corporate credit hedge

Situation: An industrial manufacturer has $200M in concentrated receivables from 5 key customers. A default by any one could threaten liquidity. The company wants to hedge without notifying customers or changing commercial terms.

Structure:

Component	Specification
Reference entities	5 customers (named)
Notional per reference	$40M each
Protection term	3 years
Credit events	Bankruptcy, failure to pay
Premium	150bps annually

Economics:

Annual premium: $200M × 1.50% = $3M
Maximum payout: $200M (if all 5 default)
Expected payout: ~$1M (based on IG default rates)

Value proposition:
- Insures against concentrated counterparty risk
- Protects liquidity in stress scenario
- No impact on customer relationships
- Premium is cost of risk management

Comparison to alternatives:

Credit insurance: Would require customer notification and credit limits
Factoring: Would require changing payment terms
Letter of credit: Would require customer cooperation
CLN hedge: Invisible to counterparties

Key takeaways

Synthetic works for risk transfer, not funding. If you need cash, use cash securitization.
Regulatory recognition is everything. Without SRT approval, you do not get capital relief. Engage your regulator early.
Credit event definitions are the critical negotiation. Misalignment between how you recognize losses and how the CLN pays creates basis risk.
Mezzanine is where the action is. First-loss is retained; senior is cheap. Mezzanine carries the risk transfer and earns the return.
Correlation is your enemy (as mezzanine investor). Higher correlation means fatter tails. Price for it.
Speed is a real advantage. 8-12 weeks vs. 4-6 months for cash securitization. If quarter-end capital relief matters, synthetic delivers faster.

Cross-references

Significant Risk Transfer (SRT) — Detailed regulatory framework
Term Securitization (ABS/MBS) — Cash securitization comparison
Rated Note Feeders — Insurance-focused CLN structures
Portfolio Valuation — Reference portfolio assessment